Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-649-3 | CAS number: 29461-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
For this endpoint there is one study available in which the potential of the test item to induce gene mutations was investigated in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and Escherichia colistrain WP2uvrA.
The assay was performed in two independent experiments both with and without liver microsomal activation (S9). Each concentration, including the controls, was tested in triplicate.The concentrations in the pre-experiment (experiment I) were: 3; 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate. The concentrations in experiment II were for TA 100: 3; 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate and for all others: 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate.
The plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in all strains used.
Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), or a tendency of higher mutation rates with increasing concentrations did not reach the threshold. The acceptance criteria were met. Therefore, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used and is considered to be non-mutagenic in the reverse mutation assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02.09.2016 - 14.09.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 preparation
- Test concentrations with justification for top dose:
- Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate.
Experiment II for TA 100: 3; 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate and for all others: 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine, 4-NOPD; 2-aminoanthracene, 2-AA
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) and preincubation
DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS: 3
ACCEPTANCE CRITERIA
- Regular background growth in the negative and solvent control
- The spontaneous reversion rates in the negative and solvent control must be in the range of our historical data
- The positive control substances should produce an increase above the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control
- A minimum of five analysable dose levels should be present with at least three dose levels showing no signs of toxic effects, evident as a reduction in the number of revertants below the indication factor of 0.5. - Evaluation criteria:
- - A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
- A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
- An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
- A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 333 µg/plate in Experiment I, not in Experiment II
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In Experiment I, without S9 at 100-5000 µg/plate and with S9 at 333-5000µg/plate. In Experiment II, without S9 at 333-5000 µg/plate and with S9 at 333-5000µg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No relevant toxic effects, evident as a dose dependent reduction of the number of revertants below 0.5 times the corresponding solvent control, occurred in the test groups with and without metabolic activation in strain TA 1537. The moderate reduction in the number of revertants in strain in experiment I without S9 mix was not dose dependent and thus judged to be based upon statistical fluctuations at such low numbers of colonies and does not represent a true toxic effect.
- Conclusions:
- The test item is considered to be non-mutagenic.
- Executive summary:
This study was performed to investigate the potential of the test item to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and Escherichia coli strain WP2uvrA.
The assay was performed in two independent experiments both with and without liver microsomal activation (S9). Each concentration, including the controls, was tested in triplicate. The concentrations in the pre-experiment (experiment I) were: 3; 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate The concentrations in experiment II were for TA 100: 3; 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate and for all others: 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate.
The test item precipitated in the overlay agar in the test tubes from 1000 to 5000 μg/plate. Precipitation of the test item in the overlay agar on the incubated agar plates was observed from 2500 to 5000 μg/plate without metabolic activation and at 5000 μg/plate with metabolic activation in the first experiment and at 5000 μg/plate without metabolic activation in the second experiment.
The plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in all strains used.
Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in strain TA 100 in both experiments.
There was no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance with the exception of strain TA 1535 in the absence of metabolic activation in experiment I. This strain showed an increase in revertant colony numbers at the highest applied concentration, which showed precipitation too. However, the absolute numbers of colonies did not reach the threshold of 3.0.
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies. The acceptance criteria were met.
During the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Therefore, the test item is considered to be non-mutagenic in the reverse mutation assay.
Reference
Summary results:
Experiment I
Without Metabolic Activation |
||||||
Test Group |
Dose level (µg/plate) |
Revertant Colony Counts (mean±SD) |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||
DMSO |
n.a. |
8±2 |
17±2 |
21±5 |
176±30 |
35±3 |
Untreated |
n.a. |
10 ± 5 |
19 ± 2 |
23 ± 12 |
184 ± 10 |
47 ± 1 |
Test item |
3 |
7 ± 3 |
27 ± 10 |
25 ± 3 |
177 ± 7 |
35 ± 7 |
|
10 |
11 ± 1 |
24 ± 9 |
21 ± 7 |
186 ± 10 |
34 ± 2 |
|
33 |
12 ± 1 |
23 ± 5 |
19 ± 4 |
157 ± 6 |
35 ± 2 |
|
100 |
12 ± 5 |
9 ± 1 |
20 ± 4 |
60 ± 4 |
34 ± 6 |
|
333 |
9 ± 2 |
7 ± 1 |
26 ± 10 |
45 ± 15 |
40 ± 6 |
|
1000 |
7 ± 3 |
8 ± 3 |
30 ± 5 |
55 ± 6 |
40 ± 6 |
|
2500 |
14 ± 6P |
14 ± 2P |
28 ± 4P |
47 ± 2P |
35 ± 3P |
|
5000 |
24 ± 1P |
10 ± 3P |
27 ± 8P |
55 ± 1P |
36 ± 11P |
NaN3 |
10 |
1236 ± 41 |
|
|
2100 ± 87 |
|
4-NOPD |
10 |
|
|
475 ± 65 |
|
|
4-NOPD |
50 |
|
86 ± 10 |
|
|
|
MMS |
2.0 |
|
|
|
|
954 ± 46 |
|
||||||
With Metabolic Activation |
||||||
Test Group |
Dose level (µg/plate) |
Revertant Colony Counts (mean +/- SD) |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||
DMSO |
n.a. |
11 ± 3 |
27 ± 5 |
30 ± 7 |
177 ± 13 |
54 ± 11 |
Untreated |
n.a. |
10 ± 2 |
25 ± 1 |
42 ± 7 |
175 ± 10 |
54 ± 11 |
Test item |
3 |
10 ± 5 |
23 ± 2 |
40 ± 10 |
139 ± 13 |
48 ± 8 |
|
10 |
15 ± 5 |
31 ± 4 |
30 ± 8 |
157 ± 10 |
48 ± 8 |
|
33 |
11 ± 6 |
24 ± 4 |
34 ± 5 |
163 ± 8 |
53 ± 6 |
|
100 |
9 ± 3 |
30 ± 2 |
31 ± 3 |
105 ± 24 |
54 ± 3 |
|
333 |
9 ± 4 |
20 ± 3 |
29 ± 8 |
51 ± 8 |
47 ± 5 |
|
1000 |
12 ± 5 |
20 ± 3 |
27 ± 5 |
24 ± 7 |
41 ± 10 |
|
2500 |
6 ± 1 |
25 ± 2 |
21 ± 1 |
10 ± 2 |
32 ± 8 |
|
5000 |
10 ± 4P |
23 ± 7P |
25 ± 5P |
11 ± 2P |
34 ± 8P |
2-AA |
2.5 |
394 ± 25 |
421 ± 28 |
4235 ± 1180 |
5176 ± 85 |
|
2-AA |
10 |
|
|
|
|
438 ± 12 |
NaN3: sodium azide
2-AA: 2-aminoanthracene
4-NOPD: 4-nitro-o-phenylene-diamine
MMS: methyl methane sulfonate
P: Precipitate
Experiment II
Without Metabolic Activation |
||||||
Test Group |
Dose level (µg/plate) |
Revertant Colony Counts (mean±SD) |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||
DMSO |
n.a. |
12±3 |
12±2 |
22±3 |
145±16 |
37±6 |
Untreated |
n.a. |
9 ± 5 |
12 ± 3 |
38 ± 8 |
181 ± 21 |
40 ± 11 |
Test item |
3 |
|
|
|
128 ± 3 |
|
|
10 |
13 ± 2 |
13 ± 4 |
28 ± 6 |
140 ± 10 |
43 ± 5 |
|
33 |
13 ± 3 |
12 ± 5 |
28 ± 3 |
94 ± 9 |
39 ± 8 |
|
100 |
10±2 |
14±2 |
27±7 |
81±18 |
34±5 |
|
333 |
10 ± 3 |
10 ± 5 |
28 ± 4 |
62 ± 7 |
35 ± 7 |
|
1000 |
10 ± 4 |
12 ± 3 |
28 ± 3 |
46 ± 7 |
31 ± 8 |
|
2500 |
11 ± 2 |
15 ± 5 |
26 ± 4 |
48 ± 5 |
32 ± 4 |
|
5000 |
13 ± 2P |
15 ± 1P |
27 ± 5P |
25 ± 6P M |
38 ± 4P |
NaN3 |
10 |
1215 ± 100 |
|
|
2004 ± 55 |
|
4-NOPD |
10 |
|
|
505 ± 28 |
|
|
4-NOPD |
50 |
|
91 ± 2 |
|
|
|
MMS |
2.0 |
|
|
|
|
569 ± 47 |
|
||||||
With Metabolic Activation |
||||||
Test Group |
Dose level (µg/plate) |
Revertant Colony Counts (mean +/- SD) |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||
DMSO |
n.a. |
11±1 |
18±5 |
37±12 |
131±9 |
56±9 |
Untreated |
n.a. |
15 ± 5 |
16 ± 6 |
49 ± 10 |
189 ± 3 |
65 ± 6 |
Test item |
3 |
|
|
|
110 ± 12 |
|
|
10 |
14 ± 4 |
19 ± 3 |
41 ± 6 |
134 ± 21 |
63 ± 10 |
|
33 |
14 ± 4 |
20 ± 4 |
41 ± 10 |
128 ± 7 |
50 ± 5 |
|
100 |
15±1 |
18±5 |
36±3 |
112±15 |
53±3 |
|
333 |
11 ± 4 |
25 ± 3 |
37 ± 5 |
39 ± 2 |
49 ± 6 |
|
1000 |
15 ± 1 |
26 ± 1 |
42 ± 1 |
35 ± 2 |
44 ± 4 |
|
2500 |
13 ± 4 |
21 ± 0 |
31 ± 5 |
21 ± 2 |
32 ± 1 |
|
5000 |
13 ± 1 |
22 ± 4 |
30 ± 7 |
13 ± 2 |
39 ± 4 |
2-AA |
2.5 |
326 ± 38 |
242 ± 4 |
3304 ± 213 |
4011 ± 287 |
|
2-AA |
10 |
|
|
|
|
439 ± 23 |
NaN3: sodium azide
2-AA: 2-aminoanthracene
4-NOPD: 4-nitro-o-phenylene-diamine
MMS: methyl methane sulfonate
P: Precipitate
M Manual count
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
The test item did not induce gene mutations by base pair changes or frameshifts in the Ames test and is considered to be non-mutagenic in the reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.